This study also aimed to characterize ErbB signaling events involved in early breast cancer development by comparative phosphoproteomic analysis of HMLECs triggered with EGFR and ErbB3-specific ligands in the context of ErbB2 overexpression. The gene discussed is ERBB3; the disease is breast carcinoma.